News

SHARP Launches New A3 Colour Multifunction Printers in India, Makes Everyday Office Tasks Simpler and Smarter
Pvt. Ltd., a wholly owned Indian subsidiary of SHARP Corporation, Japan, has launched its latest A3 colour multifunction ...
The Manila Times41m
Press Release: Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid
Sanofi and Regeneron are committed to helping patients in the US who are prescribed Dupixent gain access to the medicine and receive the support they may need with the DUPIXENT MyWay® program. For ...
The Manila Times41m
Dupixent® (dupilumab) Approved in the U.S. as the Only Targeted Medicine to Treat Patients with Bullous Pemphigoid (BP)
Regeneron and Sanofi are committed to helping patients in the U.S. who are prescribed Dupixent gain access to the medicine and receive the support they may need with the DUPIXENT MyWay® program. For ...